找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hypertension and Hormone Mechanisms; Robert M. Carey (David A. Harrison III Distinguish Book 2007 Humana Press 2007 Angiotensin II.aldoste

[復制鏈接]
樓主: 監(jiān)督
21#
發(fā)表于 2025-3-25 06:16:13 | 只看該作者
22#
發(fā)表于 2025-3-25 09:37:49 | 只看該作者
23#
發(fā)表于 2025-3-25 12:09:44 | 只看該作者
24#
發(fā)表于 2025-3-25 19:37:11 | 只看該作者
oupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
25#
發(fā)表于 2025-3-25 20:26:40 | 只看該作者
Ernesto L. Schiffrin MD, PhD, FRCPCoupling. By its emphasis on biophysical aspects of a prevalent clinical condition, the monograph is unique in its perspective and focus. The breadth of information in the chapters all in one place will be of value to clinicians and researchers at all levels. Modern research approaches and clinical u
26#
發(fā)表于 2025-3-26 03:53:15 | 只看該作者
Cardiac and Vascular Renin-Angiotensin Systemsype 1 plasma membrane (AT.) receptor. The AT1 is a seven-transmembrane spanning, heterotrimeric G protein-coupled receptor (GPCR) that activates multiple signal transduction pathways. An AT. receptor, which in large part couples to effector pathways that antagonize the AT. effects, is also present i
27#
發(fā)表于 2025-3-26 07:10:27 | 只看該作者
Insulin Resistance and Hypertensione blood pressure, the greater the chance of myocardial infarction, heart failure, stroke, and renal disease. The CVD risk escalates further when other risk factors are present, as in patients with metabolic syndrome.
28#
發(fā)表于 2025-3-26 08:58:50 | 只看該作者
Book 2007ted areas of diagnosis and therapy...With a focus on new developments in hormones and autacoids related to hypertension, Hypertension and Hormone Mechanisms provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension..
29#
發(fā)表于 2025-3-26 14:44:48 | 只看該作者
Angiotensin IV Binding Site.). This binding site was termed as the angiotensin AT. receptor by an IUPHAR nomenclature committee (.). This AT. receptor site is pharmacologically distinct from both Ang II AT. and AT. receptors, and bound Ang II at only micromolar affinity.
30#
發(fā)表于 2025-3-26 18:55:24 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 15:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
明溪县| 绥中县| 泸溪县| 东台市| 陇南市| 扶绥县| 日喀则市| 大渡口区| 台湾省| 绥滨县| 德惠市| 城固县| 苗栗县| 凉山| 龙山县| 桑植县| 平乐县| 清镇市| 吉隆县| 武汉市| 大同县| 成安县| 德安县| 庆云县| 垦利县| 竹溪县| 广宗县| 苏尼特右旗| 龙南县| 康定县| 利津县| 威宁| 来安县| 富阳市| 吉林省| 油尖旺区| 乌鲁木齐市| 汝州市| 武安市| 尉犁县| 社旗县|